Neumora Therapeutics Inc.... (NMRA)

AI Score

Unlock

0.65

0.02 (3.17%)

At close: Apr 17, 2025, 3:59 PM

0.65

0.89%

After-hours: Apr 17, 2025, 06:21 PM EDT

Neumora Therapeutics Common Stock Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q4 2020
Period Ending	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Dec 31, 2020
Cash & Equivalents	142.15M	275.71M	150.68M	182.93M	374.04M	412.28M	204.22M	210.87M	240.94M	174.4M	291.18M	409.25M	439.14M	191.98M
Short-Term Investments	165.43M	65.59M	220.96M	239.79M	79.94M	97.28M	119.98M	134.68M	130.94M	153.11M	58.44M	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	1.21M	302K	9.85M	9.91M	9.89M	19.5M	23.51M	9.37M	13.81M	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	1.21M	1.21M	1.21M	4.77M	2.93M	4.13M	4.13M	2.3M	9.65M	4.39M	183K
Receivables	n/a	n/a	1.63M	906K	939K	668K	594K	787K	919K	585K	269K	200K	270K	148K
Inventory	n/a	n/a	n/a	n/a	n/a	-668K	n/a	n/a	50K	n/a	50K	n/a	n/a	n/a
Other Current Assets	6.48M	7.3M	n/a	n/a	n/a	n/a	n/a	13.63M	50K	50K	50K	125K	125K	125K
Total Current Assets	314.06M	348.61M	398.32M	442.79M	478.28M	525.74M	336.61M	359.96M	387.95M	340.39M	362.92M	415.6M	443.08M	193.84M
Property-Plant & Equipment	2.92M	3.93M	4.94M	5.91M	6.86M	7.89M	8.68M	9.71M	10.64M	9.7M	3.8M	4.04M	4.5M	3.92M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	2.92M	3.93M	6.15M	7.43M	17.92M	19.01M	23.34M	32.13M	38.28M	23.19M	19.91M	13.69M	8.89M	4.11M
Total Assets	316.97M	352.54M	404.47M	450.21M	496.19M	544.75M	359.95M	392.09M	426.23M	363.58M	382.84M	429.3M	451.98M	197.95M
Account Payables	3.31M	6.11M	1.08M	1.49M	337K	2.23M	8.17M	1.14M	7.15M	3.02M	1.65M	1.64M	2.51M	2.4M
Deferred Revenue	n/a	n/a	-14.45M	19.49M	21.26M	23.35M	14.44M	n/a	11.54M	15.29M	14.41M	19.1M	15.96M	5.6M
Short-Term Debt	n/a	n/a	3.61M	3.49M	3.38M	n/a	n/a	3.35M	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	10.11M	22.89M	3.98M	1.3M	6.77M	9.73M	6.95M	17.3M	10.04M	7.02M	4.26M	8.13M	6.06M	4.13M
Total Current Liabilities	29.89M	31.74M	23.13M	24.61M	25.11M	29.12M	26.09M	21.78M	23.7M	22.86M	17.93M	23.28M	20.95M	9.37M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	22K	55K	89K	122K	155K	188K	843.91M	4.55M	844.32M	730.64M	730.2M	730.24M	730.15M	281.68M
Total Long-Term Liabilities	22K	55K	89K	1.06M	2.01M	2.93M	847.4M	4.55M	849.39M	735.43M	730.93M	731.24M	731.47M	282.96M
Total Liabilities	29.91M	31.8M	23.21M	25.67M	27.12M	32.06M	873.49M	26.33M	873.08M	758.29M	748.85M	754.52M	752.42M	292.33M
Total Debt	1.85M	2.75M	3.61M	4.43M	5.23M	6.14M	6.82M	7.64M	8.44M	7.38M	1.76M	2.05M	2.55M	2.04M
Common Stock	16K	16K	16K	16K	16K	15K	16K	16K	3K	15K	15K	14K	13K	13K
Retained Earnings	-947.22M	-888.4M	-815.86M	-757.15M	-703.43M	-594.7M	-541.68M	-503.13M	-467.51M	-410.02M	-379.65M	-336.61M	-309.64M	-99.29M
Comprehensive Income	62K	105K	-187K	-148K	-76K	-311K	-448K	-298K	-774K	-870K	-178K	n/a	n/a	n/a
Shareholders Equity	287.06M	320.74M	381.26M	424.54M	469.08M	512.69M	-513.54M	365.77M	-446.85M	-394.71M	-366.02M	-325.22M	-300.45M	-94.38M
Total Investments	165.43M	65.59M	222.17M	240.09M	89.79M	107.19M	129.87M	154.18M	154.45M	162.48M	72.25M	n/a	n/a	n/a